SK123997A3 - Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women - Google Patents

Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women Download PDF

Info

Publication number
SK123997A3
SK123997A3 SK1239-97A SK123997A SK123997A3 SK 123997 A3 SK123997 A3 SK 123997A3 SK 123997 A SK123997 A SK 123997A SK 123997 A3 SK123997 A3 SK 123997A3
Authority
SK
Slovakia
Prior art keywords
estradiol
month
once
norethisterone
replacement therapy
Prior art date
Application number
SK1239-97A
Other languages
English (en)
Slovak (sk)
Inventor
Ursula Lachnit-Fixson
Semiramis Aydinlik
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SK123997A3 publication Critical patent/SK123997A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SK1239-97A 1995-03-16 1996-03-15 Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women SK123997A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19510861A DE19510861A1 (de) 1995-03-16 1995-03-16 Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen
PCT/EP1996/001201 WO1996028165A1 (de) 1995-03-16 1996-03-15 Einmonatsspritze als depot-kontrazeptivum und für die hormonersatztherapie für peri- und praemenopausale frauen

Publications (1)

Publication Number Publication Date
SK123997A3 true SK123997A3 (en) 1998-02-04

Family

ID=7757668

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1239-97A SK123997A3 (en) 1995-03-16 1996-03-15 Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women

Country Status (17)

Country Link
EP (1) EP0814811A1 (ko)
JP (1) JPH11501649A (ko)
KR (1) KR19980703058A (ko)
AR (1) AR002283A1 (ko)
AU (1) AU713258B2 (ko)
CA (1) CA2215382A1 (ko)
CZ (1) CZ289697A3 (ko)
DE (1) DE19510861A1 (ko)
HU (1) HUP9801691A3 (ko)
IL (1) IL117516A (ko)
MX (1) MX9707009A (ko)
NO (1) NO974255L (ko)
NZ (1) NZ304027A (ko)
PL (1) PL322202A1 (ko)
SK (1) SK123997A3 (ko)
WO (1) WO1996028165A1 (ko)
ZA (1) ZA962177B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Also Published As

Publication number Publication date
IL117516A0 (en) 1996-07-23
HUP9801691A2 (hu) 1998-11-30
AU5110896A (en) 1996-10-02
EP0814811A1 (de) 1998-01-07
NZ304027A (en) 2000-05-26
NO974255D0 (no) 1997-09-15
ZA962177B (en) 1996-07-29
MX9707009A (es) 1997-11-29
CA2215382A1 (en) 1996-09-19
CZ289697A3 (en) 1997-12-17
HUP9801691A3 (en) 1999-03-01
PL322202A1 (en) 1998-01-19
AU713258B2 (en) 1999-11-25
JPH11501649A (ja) 1999-02-09
NO974255L (no) 1997-11-14
IL117516A (en) 2000-07-26
KR19980703058A (ko) 1998-09-05
DE19510861A1 (de) 1996-09-19
WO1996028165A1 (de) 1996-09-19
AR002283A1 (es) 1998-03-11

Similar Documents

Publication Publication Date Title
US5888543A (en) Oral contraceptives
US5858405A (en) Oral contraceptive
HU221169B1 (en) Use of estrogen and antiprogestin for producing pharmaceutical compositions useful in hormon replacement therapy and kit containing the same
US20120202779A1 (en) Management of breakthrough bleeding in extended hormonal contraceptive regimens
DE69729956T2 (de) Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält
US5747480A (en) Oral contraceptive
DE60218881T2 (de) Verfahren zur vorbeugung oder behandlung von benignen gynäkologischen störungen
US6479475B1 (en) Oral contraceptive
WO1998004246A2 (en) Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
EP0917466B1 (en) Oral contraceptive
US6451778B1 (en) Oral contraceptive
AU759925B2 (en) Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin
DE69724796T2 (de) Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten
SK123997A3 (en) Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women
US20010006963A1 (en) Once-a-month injection as a depot contraceptive and for hormone replacement therapy for perimenopausal and premenopausal women
EP1007052A1 (en) Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
WO1998004266A1 (en) Oral contraceptive
Mahapatra et al. Ethinyl Estradiol+ Dienogest.
JPH08508502A (ja) 骨粗しょう症の治療方法および治療用組成物
AU2011226911B2 (en) Management of breakthrough bleeding in extended hormonal contraceptive regimens
CN1178465A (zh) 一月针剂作为长效避孕药和用于绝经期间和绝经期前妇女的激素替代治疗
MXPA99000883A (en) Oral contraceptive
MXPA99000801A (en) Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
WO1997041869A1 (en) Oral contraceptive